Genoss Co., Ltd.
Clinical trials sponsored by Genoss Co., Ltd., explained in plain language.
-
New heart stent under scrutiny in major Real-World registry
Disease control ENROLLING_BY_INVITATIONThis study is observing how well a new type of heart stent works in everyday medical practice. The stent, called GENOSS DES, is coated with a medicine and a polymer that dissolves over time. Researchers are tracking 1,000 patients with blocked heart arteries to see if the stent s…
Sponsor: Genoss Co., Ltd. • Aim: Disease control
Last updated Apr 02, 2026 06:41 UTC
-
New heart stent under Real-World scrutiny
Disease control OngoingThis study is observing how well a new type of drug-coated heart stent works and how safe it is for patients with acute coronary syndrome (like a heart attack or unstable angina). It will follow 757 patients in South Korea who receive this specific stent during a procedure to ope…
Sponsor: Genoss Co., Ltd. • Aim: Disease control
Last updated Apr 02, 2026 06:41 UTC
-
New heart stent under Real-World scrutiny in major patient study
Disease control OngoingThis study is observing how well a new type of drug-coated stent (called GENOSS SES) works and how safe it is for people with blocked heart arteries (coronary artery disease). It will follow over 1,100 patients who receive this stent as part of their standard care. The main goal …
Sponsor: Genoss Co., Ltd. • Aim: Disease control
Last updated Apr 02, 2026 06:41 UTC
-
New balloon treatment aims to keep tiny heart arteries open
Disease control ENROLLING_BY_INVITATIONThis study is observing how well a special balloon works for people with new blockages in their small heart arteries. The balloon is coated with a drug (paclitaxel) meant to help keep the artery open after it's stretched. Researchers will follow 3,000 patients for up to 3 years t…
Sponsor: Genoss Co., Ltd. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New balloon treatment aims to keep leg arteries open
Disease control ENROLLING_BY_INVITATIONThis study is observing how well a special drug-coated balloon works to treat blocked arteries in the leg. It will follow 200 patients for one year after their procedure to see if the artery stays open and to check for any safety issues. The goal is to gather real-world informati…
Sponsor: Genoss Co., Ltd. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New heart stent under scrutiny in major 1,000-Patient study
Disease control ENROLLING_BY_INVITATIONThis study is observing 1,000 patients with blockages in multiple heart arteries who receive a specific type of drug-coated stent. The goal is to see how safe and effective this stent is over time by tracking heart-related problems. It is an observational study, meaning patients …
Sponsor: Genoss Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New heart device aims to stop stents from clogging again
Disease control ENROLLING_BY_INVITATIONThis study is testing a new medical device called the Genoss® SCB, which is a drug-coated balloon, to see if it works as well as an existing treatment for a condition where a previously placed heart stent becomes narrowed again. The trial will enroll 94 patients who have this re-…
Phase: NA • Sponsor: Genoss Co., Ltd. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New balloon treatment aims to keep leg arteries open
Disease control ENROLLING_BY_INVITATIONThis study is tracking 300 patients with blocked leg arteries who received a special balloon treatment coated with a drug called paclitaxel. The goal is to see how safe and effective the treatment is at keeping the arteries open and preventing the need for more procedures over on…
Sponsor: Genoss Co., Ltd. • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC